|
1.
|
Jaffray D, Kupelian P, Djemil T and
Macklis RM: Review of image-guided radiation therapy. Expert Rev
Anticancer Ther. 7:89–103. 2007. View Article : Google Scholar
|
|
2.
|
Eke I and Cordes N: Radiobiology goes 3D:
how ECM and cell morphology impact on cell survival after
irradiation. Radiother Oncol. 99:271–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Bortfeld T and Jeraj R: The physical basis
and future of radiation therapy. Br J Radiol. 84:485–498. 2011.
View Article : Google Scholar
|
|
4.
|
Hunter KU and Eisbruch A: Advances in
imaging: target delineation. Cancer J. 17:151–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Begg AC, Stewart FA and Vens C: Strategies
to improve radiotherapy with targeted drugs. Nat Rev Cancer.
11:239–253. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bhide SA and Nutting CM: Recent advances
in radiotherapy. BMC Med. 8:252010. View Article : Google Scholar
|
|
7.
|
Chen GT, Sharp GC and Mori S: A review of
image-guided radiotherapy. Radiol Phys Technol. 2:1–12. 2009.
View Article : Google Scholar
|
|
8.
|
Okunieff P, Chen Y, Maguire DJ and Huser
AK: Molecular markers of radiation-related normal tissue toxicity.
Cancer Metastasis Rev. 27:363–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Galbán S, Brisset JC, Rehemtulla A,
Chenevert TL, Ross BD and Galbán CJ: Diffusion-weighted MRI for
assessment of early cancer treatment response. Curr Pharm
Biotechnol. 11:701–708. 2010.PubMed/NCBI
|
|
10.
|
Thoeny HC and Ross BD: Predicting and
monitoring cancer treatment response with diffusion-weighted MRI. J
Magn Reson Imaging. 32:2–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Verellen D, Depuydt T, Gevaert T, Linthout
N, Tournel K, Duchateau M, Reynders T, Storme G and De Ridder M:
Gating and tracking, 4D in thoracic tumours. Cancer Radiother.
14:446–454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zaider M and Hanin L: Tumor control
probability in radiation treatment. Med Phys. 38:574–583. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Bentzen SM and Gregoire V: Molecular
imaging-based dose painting: a novel paradigm for radiation therapy
prescription. Semin Radiat Oncol. 21:101–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Mladenov E and Iliakis G: Induction and
repair of DNA double strand breaks: The increasing spectrum of
non-homologous end joining pathways. Mutat Res. 711:61–72. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Bekker-Jensen S and Mailand N: Assembly
and function of DNA double-strand break repair foci in mammalian
cells. DNA Repair. 9:1219–1228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Thoms J and Bristow RG: DNA repair
targeting and radiotherapy: a focus on the therapeutic ratio. Semin
Radiat Oncol. 20:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Orlowski C, Mah LJ, Vasireddy RS, El-Osta
A and Karagiannis TC: Double-strand breaks and the concept of
short-and long-term epigenetic memory. Chromosoma. 120:129–149.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Eccles LJ, O’Neill P and Lomax ME: Delayed
repair of radiation induced clustered DNA damage: friend or foe?
Mutat Res. 711:134–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Smith J, Tho LM, Xu N and Gillespie DA:
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and
cancer. Adv Cancer Res. 108:73–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Olcina M, Lecane PS and Hammond EM:
Targeting hypoxic cells through the DNA damage response. Clin
Cancer Res. 16:5624–5629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dobbs TA, Tainer JA and Lees-Miller SP: A
structural model for regulation of NHEJ by DNA-PKcs
autophosphorylation. DNA Repair. 9:1307–1314. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Sun Y, Jiang X and Price BD: Tip60:
connecting chromatin to DNA damage signaling. Cell Cycle. 99:30–36.
2010.PubMed/NCBI
|
|
23.
|
Xu Y and Price BD: Chromatin dynamics and
the repair of DNA double strand breaks. Cell Cycle. 10:261–267.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Tomita M: Involvement of DNA-PK and ATM in
radiation- and heat-induced DNA damage recognition and apoptotic
cell death. J Radiat Res (Tokyo). 51:493–501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Pawelczak KS, Bennett SM and Turchi JJ:
Coordination of DNA-PK activation and nuclease processing of DNA
termini in NHEJ. Antioxid Redox Signal. 14:2531–2543. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Bischoff P, Altmeyer A and Dumont F:
Radiosensitising agents for the radiotherapy of cancer: advances in
traditional and hypoxia targeted radiosensitisers. Expert Opin Ther
Pat. 19:643–662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Bussink J, Kaanders JH and van der Kogel
AJ: Tumor hypoxia at the micro-regional level: clinical relevance
and predictive value of exogenous and endogenous hypoxic cell
markers. Radiother Oncol. 67:3–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Rothkamm K and Horn S: gamma-H2AX as
protein biomarker for radiation exposure. Ann Ist Super Sanita.
45:265–271. 2009.PubMed/NCBI
|
|
29.
|
Sak A and Stuschke M: Use of γH2AX and
other biomarkers of double-strand breaks during radiotherapy. Semin
Radiat Oncol. 20:223–231. 2010.
|
|
30.
|
Weichselbaum RR and Kufe D: Translation of
the radio- and chemo-inducible TNFerade vector to the treatment of
human cancers. Cancer Gene Ther. 16:609–619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Wyrobek AJ, Manohar CF, Krishnan VV,
Nelson DO, Furtado MR, Bhattacharya MS, Marchetti F and Coleman MA:
Low dose radiation response curves, networks and pathways in human
lymphoblastoid cells exposed from 1 to 10 cGy of acute gamma
radiation. Mutat Res. 722:119–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Blankenberg FG and Norfray JF:
Multimodality molecular imaging of apoptosis in oncology. Am J
Roentgenol. 197:308–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Rodriguez-Rocha H, Garcia-Garcia A,
Panayiotidis MI and Franco R: DNA damage and autophagy. Mutat Res.
711:158–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Chen S, Rehman SK, Zhang W, Wen A, Yao L
and Zhang J: Autophagy is a therapeutic target in anticancer drug
resistance. Biochim Biophys Acta. 1806:220–229. 2010.PubMed/NCBI
|
|
35.
|
Yoon JH, Ahn SG, Lee H, Jung SH and Oh SH:
Role of autophagy in chemoresistance: regulation of the
ATM-mediated DNA-damage signaling pathway through activation of
DNA-PKcs and PARP-1. Biochem Pharmacol. 83:747–757. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Hennequin C, Quero L and Favaudon V:
Determinants and predictive factors of tumour radiosensitivity.
Cancer Radiother. 12:3–13. 2008.
|
|
37.
|
Gravina GL, Festuccia C, Marampon F, Popov
VM, Pestell RG, Zani BM and Tombolini V: Biological rationale for
the use of DNA methyltransferase inhibitors as new strategy for
modulation of tumor response to chemotherapy and radiation. Mol
Cancer. 9:3052010. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Pauwels B, Wouters A, Peeters M, Vermorken
JB and Lardon F: Role of cell cycle perturbations in the
combination therapy of chemotherapeutic agents and radiation.
Future Oncol. 6:1485–1496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Takekawa M, Kubota Y, Nakamura T and
Ichikawa K: Regulation of stress-activated MAP kinase pathways
during cell fate decisions. Nagoya J Med Sci. 73:1–14.
2011.PubMed/NCBI
|
|
40.
|
Kim J, Meyer JL and Dawson LA: Image
guidance and the new practice of radiotherapy: what to know and use
from a decade of investigation. Front Radiat Ther Oncol.
43:196–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Vral A, Fenech M and Thierens H: The
micronucleus assay as a biological dosimeter of in vivo ionising
radiation exposure. Mutagenesis. 26:11–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Parliament MB and Murray D: Single
nucleotide polymorphisms of DNA repair genes as predictors of
radioresponse. Semin Radiat Oncol. 20:232–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Baskar R: Emerging role of radiation
induced bystander effects: Cell communications and carcinogenesis.
Genome Integr. 1:132010. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Cao Y: The promise of dynamic
contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol.
21:147–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Yarnold J and Brotons MC: Pathogenetic
mechanisms in radiation fibrosis. Radiother Oncol. 97:149–161.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Heneweer C and Grimm J: Clinical
applications in molecular imaging. Pediatr Radiol. 41:199–207.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Müller K and Meineke V: Radiation-induced
alterations in cytokine production by skin cells. Exp Hematol.
35(Suppl 1): 96–104. 2007.PubMed/NCBI
|
|
48.
|
Kong FM, Ao X, Wang L and Lawrence TS: The
use of blood biomarkers to predict radiation lung toxicity: a
potential strategy to individualize thoracic radiation therapy.
Cancer Control. 15:140–150. 2008.PubMed/NCBI
|
|
49.
|
Deorukhkar A and Krishnan S: Targeting
inflammatory pathways for tumor radiosensitization. Biochem
Pharmacol. 80:1904–1914. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Fritz G, Henninger C and Huelsenbeck J:
Potential use of HMG-CoA reductase inhibitors (statins) as
radioprotective agents. Br Med Bull. 97:17–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Bussink J, van Herpen CM, Kaanders JH and
Oyen WJ: PET-CT for response assessment and treatment adaptation in
head and neck cancer. Lancet Oncol. 11:661–669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Castadot P, Lee JA, Geets X and Grégoire
V: Adaptive radiotherapy of head and neck cancer. Semin Radiat
Oncol. 20:84–93. 2010. View Article : Google Scholar
|
|
53.
|
Peng Q, Li J, Feng M, Xiao MY and Lang JY:
A study of replanning during the course of IMRT for nasopharyngeal
carcinoma. J Cancer Control Treat. 24:45–47. 2011.(In Chinese).
|
|
54.
|
Wang X, Lu JD, Xu XP, Zhu GP, Ying HM, He
SQ, Hu WG and Hu CS: Anatomic and dosimetric changes during the
treatment course of intensity-modulated radiotherapy for locally
advanced nasopharyngeal carcinoma. Med Dosim. 35:151–157. 2010.
View Article : Google Scholar
|
|
55.
|
Wang W, Yang H, Hu W, Shan G, Ding W, Yu
C, Wang B, Wang X and Xu Q: Clinical study of the necessity of
replanning before the 25th fraction during the course of
intensity-modulated radiotherapy for patients with nasopharyngeal
carcinoma. Int J Radiat Oncol Biol Phys. 77:617–621. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Hansen KE, Bucci MK, Quivey JM, Weinberg V
and Xia P: Repeat CT imaging and replanning during the course of
IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys.
64:355–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Mechalakos J, Lee N, Hunt M, Ling CC and
Amols HI: The effect of significant tumor reduction on the dose
distribution in intensity modulated radiation therapy for head and
neck cancer: a case study. Med Dosim. 34:250–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Zhao L, Wan Q, Zhou Y, Deng X, Xie C and
Wu S: The role of replanning in fractionated intensity modulated
radiotherapy for nasopharyngeal carcinoma. Radiother Oncol.
98:23–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Zhang Y and Li J: A study on necessity of
radiotherapy replanning for non-small cell lung cancer. Int J
Radiat Oncol Biol Phys. 78:S541–S542. 2010. View Article : Google Scholar
|
|
60.
|
Søvik A, Malinen E and Olsen DR:
Strategies for biologic image-guided dose escalation: a review. Int
J Radiat Oncol Biol Phys. 73:650–658. 2009.PubMed/NCBI
|
|
61.
|
Purdy JA: Dose to normal tissues outside
the radiation therapy patient’s treated volume: a review of
different radiation therapy techniques. Health Phys. 95:666–676.
2008.
|
|
62.
|
Guha C, Alfieri A, Blaufox MD and Kalnicki
S: Tumor biology-guided radiotherapy treatment planning: gross
tumor volume versus functional tumor volume. Semin Nucl Med.
38:105–113. 2008.PubMed/NCBI
|
|
63.
|
Thorwarth D and Schaefer A: Functional
target volume delineation for radiation therapy on the basis of
positron emission tomography and the correlation with
histopathology. Q J Nucl Med Mol Imaging. 54:490–499.
2010.PubMed/NCBI
|
|
64.
|
Thorwarth D, Geets X and Paiusco M:
Physical radiotherapy treatment planning based on functional PET/CT
data. Radiother Oncol. 96:317–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
